204 related articles for article (PubMed ID: 36116709)
1. Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies.
Wu W; Xue X; Chen Y; Zheng N; Wang J
Pharmacol Res; 2022 Oct; 184():106456. PubMed ID: 36116709
[TBL] [Abstract][Full Text] [Related]
2. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.
Zhang Z; Yu W; Zheng M; Liao X; Wang J; Yang D; Lu W; Wang L; Zhang S; Liu H; Zhou XZ; Lu KP
Mol Carcinog; 2019 Aug; 58(8):1450-1464. PubMed ID: 31026381
[TBL] [Abstract][Full Text] [Related]
3. Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells.
Kozono S; Lin YM; Seo HS; Pinch B; Lian X; Qiu C; Herbert MK; Chen CH; Tan L; Gao ZJ; Massefski W; Doctor ZM; Jackson BP; Chen Y; Dhe-Paganon S; Lu KP; Zhou XZ
Nat Commun; 2018 Aug; 9(1):3069. PubMed ID: 30093655
[TBL] [Abstract][Full Text] [Related]
4. The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer.
Namgoong GM; Khanal P; Cho HG; Lim SC; Oh YK; Kang BS; Shim JH; Yoo JC; Choi HS
J Biol Chem; 2010 Jul; 285(31):23829-41. PubMed ID: 20479004
[TBL] [Abstract][Full Text] [Related]
5. Recent advances of Pin1 inhibitors as potential anticancer agents.
Bai Y; Yuan Z; Yuan S; He Z
Bioorg Chem; 2024 Mar; 144():107171. PubMed ID: 38325131
[TBL] [Abstract][Full Text] [Related]
6. Prolyl isomerase Pin1 regulates cadmium-induced autophagy via ubiquitin-mediated post-translational stabilization of phospho-Ser GSK3αβ in human hepatocellular carcinoma cells.
So KY; Oh SH
Biochem Pharmacol; 2015 Dec; 98(3):511-21. PubMed ID: 26445356
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.
Zheng M; Xu H; Liao XH; Chen CP; Zhang AL; Lu W; Wang L; Yang D; Wang J; Liu H; Zhou XZ; Lu KP
Oncotarget; 2017 May; 8(18):29771-29784. PubMed ID: 28404959
[TBL] [Abstract][Full Text] [Related]
8. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cardiac hypertrophic signaling by prolyl isomerase Pin1.
Toko H; Konstandin MH; Doroudgar S; Ormachea L; Joyo E; Joyo AY; Din S; Gude NA; Collins B; Völkers M; Thuerauf DJ; Glembotski CC; Chen CH; Lu KP; Müller OJ; Uchida T; Sussman MA
Circ Res; 2013 Apr; 112(9):1244-52. PubMed ID: 23487407
[TBL] [Abstract][Full Text] [Related]
10. The role of Pin1 in the development and treatment of cancer.
Min SH; Zhou XZ; Lu KP
Arch Pharm Res; 2016 Dec; 39(12):1609-1620. PubMed ID: 27572155
[TBL] [Abstract][Full Text] [Related]
11. Development of Pin1 Inhibitors and their Potential as Therapeutic Agents.
Nakatsu Y; Matsunaga Y; Ueda K; Yamamotoya T; Inoue Y; Inoue MK; Mizuno Y; Kushiyama A; Ono H; Fujishiro M; Ito H; Okabe T; Asano T
Curr Med Chem; 2020; 27(20):3314-3329. PubMed ID: 30394205
[TBL] [Abstract][Full Text] [Related]
12. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
13. Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 associates with insulin receptor substrate-1 and enhances insulin actions and adipogenesis.
Nakatsu Y; Sakoda H; Kushiyama A; Zhang J; Ono H; Fujishiro M; Kikuchi T; Fukushima T; Yoneda M; Ohno H; Horike N; Kanna M; Tsuchiya Y; Kamata H; Nishimura F; Isobe T; Ogihara T; Katagiri H; Oka Y; Takahashi S; Kurihara H; Uchida T; Asano T
J Biol Chem; 2011 Jun; 286(23):20812-22. PubMed ID: 21454638
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1.
Urusova DV; Shim JH; Kim DJ; Jung SK; Zykova TA; Carper A; Bode AM; Dong Z
Cancer Prev Res (Phila); 2011 Sep; 4(9):1366-77. PubMed ID: 21750208
[TBL] [Abstract][Full Text] [Related]
15. The role of PIN1 on odontogenic and adipogenic differentiation in human dental pulp stem cells.
Lee YM; Shin SY; Jue SS; Kwon IK; Cho EH; Cho ES; Park SH; Kim EC
Stem Cells Dev; 2014 Mar; 23(6):618-30. PubMed ID: 24219242
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer.
Ding Q; Huo L; Yang JY; Xia W; Wei Y; Liao Y; Chang CJ; Yang Y; Lai CC; Lee DF; Yen CJ; Chen YJ; Hsu JM; Kuo HP; Lin CY; Tsai FJ; Li LY; Tsai CH; Hung MC
Cancer Res; 2008 Aug; 68(15):6109-17. PubMed ID: 18676833
[TBL] [Abstract][Full Text] [Related]
17. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer.
Wei S; Kozono S; Kats L; Nechama M; Li W; Guarnerio J; Luo M; You MH; Yao Y; Kondo A; Hu H; Bozkurt G; Moerke NJ; Cao S; Reschke M; Chen CH; Rego EM; Lo-Coco F; Cantley LC; Lee TH; Wu H; Zhang Y; Pandolfi PP; Zhou XZ; Lu KP
Nat Med; 2015 May; 21(5):457-66. PubMed ID: 25849135
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
19. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
[TBL] [Abstract][Full Text] [Related]
20. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation.
Liao Y; Wei Y; Zhou X; Yang JY; Dai C; Chen YJ; Agarwal NK; Sarbassov D; Shi D; Yu D; Hung MC
Oncogene; 2009 Jul; 28(26):2436-45. PubMed ID: 19448664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
